Parathyroid 2012: New Advances in the Diagnosis and Treatment of Parathyroid Disease participants will learn up-to-date algorithms for the diagnosis and treatment of parathyroid disease from internationally renowned keynote speakers who have helped to define these guidelines. A unique panel of expert's format will permit key questions to be posed to nationally prominent endocrinologists & endocrine surgeons in search of consensus strategies. Moreover, this gathering of specialists from across medical and surgical disciplines offers the opportunity for appreciating varying perspectives on the optimal delivery of patient care.
The combined format of live debate and didactic presentations will allow participants to observe and question faculty practitioners as they deal with real patient problems, and demonstrate how to apply new information and evidence based guidelines into their practices. This course will evaluate the recent advances in diagnostic and therapeutic approaches to parathyroid disease that have altered traditional management paradigms. New guidelines and optimal surgical protocols will be introduced, which are intended to enhance the current knowledge, allowing health professionals to appropriately refer patients for surgery and order optimal pre- and post-operative evaluations for patients.
Featured Keynote Speakers:
John P. Bilezikian, MD
Professor, Department of Medicine
Brendan C. Stack Jr. MD, FACS, FACE
Professor and Chair Department of Otolaryngology-Head & Neck Surgery
University of Arkansas
Jefferson Medical College of Thomas Jefferson University is accredited by the ACCME to provide continuing medical education for physicians.
Faculty Disclosure Statement:
All faculty participating in continuing medical education activities sponsored by Jefferson Medical College are expected to disclose to the activity audience any real or apparent conflict(s) of interest related to the content of their presentation(s). Full disclosure of faculty relationships will be made at this activity.
At the conclusion of this conference, participants should be able to:
- Examine and implement into practice the new Guidelines from the Third Consensus Development Conference on the Management of Asymptomatic Primary Hyperparathyroidism.
- Analyze the indications for newly developed pharmacotherapy agents and identify their utility in treating the hyperparathyroid patient.
- Differentiate secondary hyperparathyroidism due to vitamin D deficiency from primary hyperparathyroidism on the basis of serological testing and develop a treatment strategy.
- Identify the causes of secondary hyperparathyroidism and integrate into practice established protocols for the treatment of the specific causes, e.g., vitamin D deficiency, celiac disease, and renal failure.
- Critique the new guidelines for the surgical treatment of parathyroid gland disorders and select the appropriate surgical treatment option based on cure and completion rates.
- Evaluate and integrate into practice various operative adjuncts to assist in surgery including intraoperative PTH monitoring, gamma probe with preoperative sestamibi injection, and intraoperative laryngeal nerve monitoring, venous sampling and ultrasonography.
- Based on the surgical protocols, identify patients for surgery, order optimal preoperative evaluations and discuss potential complications with patients.
- Assess their individual practice in light of the information and discussions during the course, and identify specific strategies to implement as part of a continuing improvement process for their practices.
Jefferson Medical College designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Download Agenda | Download Brochure | Exhibitors | Hotel Information
Online registration is now closed. Individuals interested in attending can register on-site for this conference.